BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kiadis Pharma 

Zernikepark 6-8

Groningen    9747 AN  The Netherlands
Phone: 31-0-50-547-42-70 Fax: 31-0-50-547-42-71


SEARCH JOBS





Segment
Oncology





 Company News
Kiadis Pharma Appoints Jeroen Rovers As Its Chief Medical Officer 9/3/2014 11:29:45 AM
Kiadis Pharma Initiates Collaboration For Personalized Immunotherapies Using ATIRTM With Technische Universitat Munchen Within Munich Biotech Cluster 1/29/2014 9:20:00 AM
Kiadis Pharma Participates In Haploidentical Transplantation 2013 Forum 12/5/2013 6:22:55 AM
Kiadis Pharma Provides Positive Update On Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ 11/18/2013 9:21:54 AM
Kiadis Pharma Secures Manufacturing Services Agreement for Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ With the German Red Cross Blood Donor Service 10/7/2013 10:08:49 AM
Kiadis Pharma Secures Manufacturing Services Agreement for Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ With the German Red Cross Blood Donor Service 10/7/2013 8:33:58 AM
Kiadis Pharma Completes Five-Year Follow-up of Its Phase I/II Clinical Study With Blood Cancer Product ATIR™ and Study Meets Primary Objective 9/11/2013 9:18:35 AM
Kiadis Pharma to Receive GMP Manufacturing License and GMP Certificate 7/23/2013 9:25:13 AM
Kiadis Pharma Awarded a €3 Million Innovation Credit From the Dutch Government for Phase II Clinical Development Program 6/26/2013 9:37:43 AM
Kiadis Pharma Receives Regulatory Approval From Health Canada for a Phase II Clinical Study With Its Blood Cancer Treatment ATIR™ 2/26/2013 11:23:36 AM
1234